JP2017189179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017189179A5 JP2017189179A5 JP2017146473A JP2017146473A JP2017189179A5 JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5 JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- host cell
- virus
- bacterial
- bacterial dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27315109P | 2009-07-31 | 2009-07-31 | |
| US61/273,151 | 2009-07-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522275A Division JP2013500712A (ja) | 2009-07-31 | 2010-07-30 | 逆遺伝学系 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017189179A JP2017189179A (ja) | 2017-10-19 |
| JP2017189179A5 true JP2017189179A5 (enExample) | 2018-02-01 |
| JP6666311B2 JP6666311B2 (ja) | 2020-03-13 |
Family
ID=43018886
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522275A Withdrawn JP2013500712A (ja) | 2009-07-31 | 2010-07-30 | 逆遺伝学系 |
| JP2015215655A Pending JP2016019547A (ja) | 2009-07-31 | 2015-11-02 | 逆遺伝学系 |
| JP2017146473A Active JP6666311B2 (ja) | 2009-07-31 | 2017-07-28 | 逆遺伝学系 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522275A Withdrawn JP2013500712A (ja) | 2009-07-31 | 2010-07-30 | 逆遺伝学系 |
| JP2015215655A Pending JP2016019547A (ja) | 2009-07-31 | 2015-11-02 | 逆遺伝学系 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9821052B2 (enExample) |
| EP (1) | EP2459722B1 (enExample) |
| JP (3) | JP2013500712A (enExample) |
| KR (1) | KR20120039047A (enExample) |
| CN (2) | CN102666860B (enExample) |
| AU (1) | AU2010277310B2 (enExample) |
| CA (1) | CA2769673A1 (enExample) |
| WO (1) | WO2011012999A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101323582B1 (ko) | 2011-03-17 | 2013-10-30 | 충북대학교 산학협력단 | Ｖｅｒｏ 세포 유래의 ｐｏｌⅠ 프로모터 및 이를 포함하는 재조합 벡터 |
| WO2013101783A2 (en) | 2011-12-30 | 2013-07-04 | Bio-Rad Laboratories, Inc. | Methods and compositions for performing nucleic acid amplification reactions |
| JP6054883B2 (ja) | 2012-03-02 | 2016-12-27 | ノバルティス アーゲー | インフルエンザウイルスの再集合 |
| JP6421128B2 (ja) | 2012-12-03 | 2018-11-07 | ノバルティス アーゲー | リアソータントインフルエンザａウイルス |
| US20140274806A1 (en) | 2013-03-15 | 2014-09-18 | Synthetic Genomics Vaccines | Influenza virus reassortment |
| SG11201505550RA (en) * | 2013-01-23 | 2015-08-28 | Novartis Ag | Influenza virus reassortment |
| JP6525469B2 (ja) | 2013-03-13 | 2019-06-05 | ノバルティス アーゲー | インフルエンザｂ型ウイルス再集合 |
| WO2014145261A2 (en) * | 2013-03-15 | 2014-09-18 | University Of Maryland | Methods and compositions for in vivo immune stimulation and antigen production |
| DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
| DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
| HK1222882A1 (zh) | 2013-06-06 | 2017-07-14 | Novartis Ag | 流感病毒重配 |
| KR101970428B1 (ko) * | 2015-03-27 | 2019-04-18 | 카딜라 핼쓰캐어 리미티드 | 재조합 볼거리 바이러스 제릴린2계 백신 |
| US10726110B2 (en) * | 2017-03-01 | 2020-07-28 | Seven Bridges Genomics, Inc. | Watermarking for data security in bioinformatic sequence analysis |
| CA3080656A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| CN114040979B (zh) * | 2019-06-21 | 2024-06-28 | 国立大学法人大阪大学 | 稳定地保持外源基因的人工重组rna病毒的制作方法 |
| CN110305854B (zh) * | 2019-07-18 | 2023-09-15 | 山东中医药大学 | 一种携带荧光素酶的重组h3n2亚型流感病毒、构建方法及应用 |
| WO2021099419A1 (en) | 2019-11-18 | 2021-05-27 | Seqirus UK Limited | Method for producing reassortant influenza viruses |
| CN114395568A (zh) * | 2021-10-29 | 2022-04-26 | 扬州大学 | 一种猪流行性腹泻病毒感染性cDNA克隆及其构建方法与应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| AU5543294A (en) | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| DE19612967A1 (de) | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren |
| TW570803B (en) | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| WO1999050419A2 (en) * | 1998-03-31 | 1999-10-07 | University Of Maryland Biotechnology Institute | A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts |
| EP2316924B1 (en) | 1998-06-12 | 2017-10-11 | Icahn School of Medicine at Mount Sinai | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| PT1098961E (pt) | 1998-06-12 | 2008-04-23 | Mount Sinai School Of Med Of T | Vírus atenuados produzidos por engenharia genética indutores de interferão |
| GB9916794D0 (en) * | 1999-07-16 | 1999-09-22 | Isis Innovation | In vitro virus reconstitution |
| HUP0202846A3 (en) | 1999-09-24 | 2003-12-29 | Smithkline Beecham Biolog | Intranasal influenza virus vaccine |
| JP4698112B2 (ja) | 2000-03-03 | 2011-06-08 | 一般財団法人化学及血清療法研究所 | 無血清培養かつ浮遊培養可能な細胞及び当該細胞を用いたワクチン用ウイルスの製造法 |
| HU229101B1 (en) | 2000-04-28 | 2013-07-29 | St Jude Childrens Res Hospital | Dna transfection system for the generation of infectious influenza virus |
| AU2001264802A1 (en) * | 2000-05-21 | 2001-12-03 | University Of North Carolina At Chapel Hill | Assembly of large viral genomes and chromosomes from subclones |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| DK1361890T3 (da) | 2001-02-23 | 2011-06-27 | Glaxosmithkline Biolog Sa | Influenzavaccineformuleringer til intradermal indgift |
| EP1361889A1 (en) | 2001-02-23 | 2003-11-19 | GlaxoSmithKline Biologicals S.A. | Novel vaccine |
| TWI228420B (en) | 2001-05-30 | 2005-03-01 | Smithkline Beecham Pharma Gmbh | Novel vaccine composition |
| EP1534845A1 (en) * | 2002-09-04 | 2005-06-01 | Polymun Scientific Immunbiologische Forschung GmbH | Generation of recombinant influenza virus using baculovirus delivery vector |
| PT1742659E (pt) | 2004-04-05 | 2013-06-03 | Pah Usa 15 Llc | Emulsões de óleo em água microfluidizadas e composições de vacinas |
| WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| AU2005245943A1 (en) | 2004-05-20 | 2005-12-01 | Id Biomedical Corporation | Process for the production of an influenza vaccine |
| CA2587510A1 (en) * | 2004-11-19 | 2007-04-19 | Wisconsin Alumni Research Foundation | Recombinant influenza vectors with tandem transcription units |
| ES2526170T3 (es) | 2004-12-23 | 2015-01-07 | Medimmune, Llc | Línea celular MDCK no tumorigénica para propagar virus |
| JP5620048B2 (ja) | 2004-12-24 | 2014-11-05 | アボツト・バイオロジカルズ・ベー・ブイＡｂｂｏｔｔ Ｂｉｏｌｏｇｉｃａｌｓ Ｂ．Ｖ． | インフルエンザウイルスの救済（ｒｅｓｃｕｅ） |
| FR2884255B1 (fr) | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| EP1917352A4 (en) | 2005-06-21 | 2009-03-25 | Medimmune Vaccines Inc | METHODS AND COMPOSITIONS FOR EXPRESSING HETEROLOGOUS PROTEASE |
| US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
| EA014062B1 (ru) | 2005-11-01 | 2010-08-30 | Новартис Вэксинс Энд Диагностикс Гмбх & Ко Кг | Вирусные вакцины, полученные из клеток с низкими уровнями остаточной клеточной днк |
| FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
| CA2646526C (en) | 2006-04-19 | 2016-01-12 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral rna in canine cells |
| HRP20130023T1 (hr) | 2006-10-12 | 2013-02-28 | Glaxosmithkline Biologicals S.A. | Cjepivo koje sadrži emulziju ulje u vodi kao adjuvans |
| EA200900784A1 (ru) | 2006-12-06 | 2009-12-30 | Новартис Аг | Вакцины, включающие антиген из четырех штаммов вируса гриппа |
| EP2045323A1 (en) * | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| DK2207899T3 (en) | 2007-10-08 | 2018-09-03 | Synthetic Genomics Inc | COLLECTION OF LARGE NUCLEIC ACIDS |
| CN101302499A (zh) * | 2008-06-30 | 2008-11-12 | 中国科学院广州生物医药与健康研究院 | 一种流感病毒疫苗种子株的制备方法 |
| EP2233568A1 (en) * | 2009-03-19 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade AG | Novel method for generation of RNA virus |
-
2010
- 2010-07-30 US US13/388,033 patent/US9821052B2/en active Active
- 2010-07-30 CN CN201080041918.0A patent/CN102666860B/zh active Active
- 2010-07-30 EP EP10754367.0A patent/EP2459722B1/en active Active
- 2010-07-30 KR KR1020127005113A patent/KR20120039047A/ko not_active Withdrawn
- 2010-07-30 WO PCT/IB2010/002137 patent/WO2011012999A1/en not_active Ceased
- 2010-07-30 JP JP2012522275A patent/JP2013500712A/ja not_active Withdrawn
- 2010-07-30 AU AU2010277310A patent/AU2010277310B2/en active Active
- 2010-07-30 CA CA2769673A patent/CA2769673A1/en not_active Abandoned
- 2010-07-30 CN CN201510264548.1A patent/CN104862335A/zh active Pending
-
2015
- 2015-11-02 JP JP2015215655A patent/JP2016019547A/ja active Pending
-
2017
- 2017-07-28 JP JP2017146473A patent/JP6666311B2/ja active Active
- 2017-10-16 US US15/784,575 patent/US10610584B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017189179A5 (enExample) | ||
| Kobayashi et al. | An improved reverse genetics system for mammalian orthoreoviruses | |
| JP2015119730A5 (enExample) | ||
| Zhou et al. | Characterization of uncultivable bat influenza virus using a replicative synthetic virus | |
| JP2019011344A5 (enExample) | ||
| Sun et al. | Rapid construction of complex plant RNA virus infectious cDNA clones for agroinfection using a yeast-E. coli-Agrobacterium shuttle vector | |
| JP2016509864A5 (enExample) | ||
| Zhang et al. | Wheat yellow mosaic virus NIb interacting with host light induced protein (LIP) facilitates its infection through perturbing the abscisic acid pathway in wheat | |
| EA201791343A1 (ru) | Композиции и способы для конструирования вирусного генома in vitro | |
| JP2016521553A5 (enExample) | ||
| JP2010042030A5 (enExample) | ||
| RU2008145226A (ru) | Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки | |
| Griffin et al. | Fitness determinants of influenza A viruses | |
| CA2968430C (en) | Plasmids and method for obtaining viral particles | |
| Mostafa et al. | Efficient generation of recombinant influenza a viruses employing a new approach to overcome the genetic instability of HA segments | |
| Zhang et al. | Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid | |
| Shao et al. | An efficient and rapid influenza gene cloning strategy for reverse genetics system | |
| Lee | Reverse genetics of influenza virus | |
| Feng et al. | Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression | |
| Park et al. | Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A (H7N9) virus in guinea pigs | |
| CN104195154A (zh) | 新城疫病毒Mukteswar中等毒力疫苗株反向遗传操作系统及其应用 | |
| Froggatt et al. | Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity | |
| CN105671002B (zh) | H9n2亚型禽流感病毒细胞高产疫苗株构建及应用 | |
| Kim et al. | Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus | |
| De Vlugt et al. | Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA |